Aptus Pharma Ltd () Stock Analysis | Price, Returns, Financials & Key Metrics

52-Week High: Rs.421.55 hit today

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

23.6 k (63.89%) Volume

Shareholding (Jun 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

72.89%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 677 Cr ()

P/E

149.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

29.49

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

91.83%

6 Months

196.87%

1 Year

1130.08%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Aptus Pharma for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Closure of Trading Window

28-Sep-2026 | Source : BSE

Closure of trading window under Insider Trading Code

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

17-Sep-2026 | Source : BSE

Intimation of Investor Meeting/Interaction

Shareholder Meeting / Postal Ballot-Scrutinizers Report

14-Sep-2026 | Source : BSE

Scrutinizers Report on remote E-Voting

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

Aptus Pharma Ltd has announced 3:2 bonus issue, ex-date: 12 May 26

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

4.28

Debt to EBITDA (avg)

1.71

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.82

Tax Ratio

27.47%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

28.87%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

149

Industry P/E

Price to Book Value

29.49

EV to EBIT

98.82

EV to EBITDA

93.38

EV to Capital Employed

23.55

EV to Sales

14.92

PEG Ratio

Dividend Yield

ROCE (Latest)

23.83%

ROE (Latest)

19.79%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Sideways

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Kapil Hasmukhbhai Chandarana (11.44%)

Highest Public shareholder

None

Individual Investors Holdings

24.03%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Aptus Pharma"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Aptus Pharma"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Aptus Pharma"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Aptus Pharma"
  }
]

Company CV

About

Company Coordinates

Company Details

Tel:

Registrar Details

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."